Dan Sheng
Director/Board Member at BEIJING STRONG BIOTECHNOLOGIES,INC.
Net worth: 907 594 $ as of 29/04/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Zuo Jun Zou | M | 66 |
Fuzhou Maixin Biotech Co., Ltd.
 Fuzhou Maixin Biotech Co., Ltd. Medical/Nursing ServicesHealth Services Part of Beijing Strong Biotechnologies, Inc., Fuzhou Maixin Biotech Co., Ltd. engages in the production, research & development, and sales of tissue-based diagnostics, specifically IHC antibodies, reagents, and the automation of IHC and ISH. The company is based in Fuzhou, China. Fuzhou Maixin Biotech Co. was acquired by Fuzhou Maixin Biotech Co. Ltd. /Private Group/ on September 30, 2020 for $255.21 million. The Chinese company was founded in 1993. The CEO is Xiao Ya Wang. | 23 years |
| Xi Liu | M | 62 |
Fuzhou Maixin Biotech Co., Ltd.
Fuzhou Maixin Biotech Co., Ltd. Medical/Nursing ServicesHealth Services Part of Beijing Strong Biotechnologies, Inc., Fuzhou Maixin Biotech Co., Ltd. engages in the production, research & development, and sales of tissue-based diagnostics, specifically IHC antibodies, reagents, and the automation of IHC and ISH. The company is based in Fuzhou, China. Fuzhou Maixin Biotech Co. was acquired by Fuzhou Maixin Biotech Co. Ltd. /Private Group/ on September 30, 2020 for $255.21 million. The Chinese company was founded in 1993. The CEO is Xiao Ya Wang. | 23 years |
| Xiao Ya Wang | M | - |
Fuzhou Maixin Biotech Co., Ltd.
Fuzhou Maixin Biotech Co., Ltd. Medical/Nursing ServicesHealth Services Part of Beijing Strong Biotechnologies, Inc., Fuzhou Maixin Biotech Co., Ltd. engages in the production, research & development, and sales of tissue-based diagnostics, specifically IHC antibodies, reagents, and the automation of IHC and ISH. The company is based in Fuzhou, China. Fuzhou Maixin Biotech Co. was acquired by Fuzhou Maixin Biotech Co. Ltd. /Private Group/ on September 30, 2020 for $255.21 million. The Chinese company was founded in 1993. The CEO is Xiao Ya Wang. | - |
| Tao Jiang | M | 61 | 10 years | |
| Jian Ding | M | 71 | 7 years | |
| Nan Bao | F | 44 | 20 years | |
| Lei Fu | M | 73 | 7 years | |
| Yong Hong Chen | M | 62 | 4 years | |
| Hong Jun Liang | M | 50 |
Fuzhou Maixin Biotech Co., Ltd.
Fuzhou Maixin Biotech Co., Ltd. Medical/Nursing ServicesHealth Services Part of Beijing Strong Biotechnologies, Inc., Fuzhou Maixin Biotech Co., Ltd. engages in the production, research & development, and sales of tissue-based diagnostics, specifically IHC antibodies, reagents, and the automation of IHC and ISH. The company is based in Fuzhou, China. Fuzhou Maixin Biotech Co. was acquired by Fuzhou Maixin Biotech Co. Ltd. /Private Group/ on September 30, 2020 for $255.21 million. The Chinese company was founded in 1993. The CEO is Xiao Ya Wang. | 4 years |
| Jian Min Wang | M | 47 |
Fuzhou Maixin Biotech Co., Ltd.
Fuzhou Maixin Biotech Co., Ltd. Medical/Nursing ServicesHealth Services Part of Beijing Strong Biotechnologies, Inc., Fuzhou Maixin Biotech Co., Ltd. engages in the production, research & development, and sales of tissue-based diagnostics, specifically IHC antibodies, reagents, and the automation of IHC and ISH. The company is based in Fuzhou, China. Fuzhou Maixin Biotech Co. was acquired by Fuzhou Maixin Biotech Co. Ltd. /Private Group/ on September 30, 2020 for $255.21 million. The Chinese company was founded in 1993. The CEO is Xiao Ya Wang. | 9 years |
| Wei Liu | F | 55 | 17 years | |
| Zhuo Yue | M | - |
Fuzhou Maixin Biotech Co., Ltd.
Fuzhou Maixin Biotech Co., Ltd. Medical/Nursing ServicesHealth Services Part of Beijing Strong Biotechnologies, Inc., Fuzhou Maixin Biotech Co., Ltd. engages in the production, research & development, and sales of tissue-based diagnostics, specifically IHC antibodies, reagents, and the automation of IHC and ISH. The company is based in Fuzhou, China. Fuzhou Maixin Biotech Co. was acquired by Fuzhou Maixin Biotech Co. Ltd. /Private Group/ on September 30, 2020 for $255.21 million. The Chinese company was founded in 1993. The CEO is Xiao Ya Wang. | 4 years |
| Cong Zhao Guo | F | 52 | 4 years | |
| Claire L. Gaudiani | M | 79 |
New York University
| 20 years |
| Lana Dubovik | F | - |
New York University
| 22 years |
| Xiao Lin Sun | M | 65 | 13 years | |
| Ai Ping Luo | M | 61 | 13 years | |
| Max Starkov | M | - |
New York University
| 23 years |
| Guo Qiang Lin | M | 81 |
University of Science & Technology of China
| 24 years |
| Mei Yun Zheng | F | - |
Fuzhou Maixin Biotech Co., Ltd.
Fuzhou Maixin Biotech Co., Ltd. Medical/Nursing ServicesHealth Services Part of Beijing Strong Biotechnologies, Inc., Fuzhou Maixin Biotech Co., Ltd. engages in the production, research & development, and sales of tissue-based diagnostics, specifically IHC antibodies, reagents, and the automation of IHC and ISH. The company is based in Fuzhou, China. Fuzhou Maixin Biotech Co. was acquired by Fuzhou Maixin Biotech Co. Ltd. /Private Group/ on September 30, 2020 for $255.21 million. The Chinese company was founded in 1993. The CEO is Xiao Ya Wang. | 7 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Hong Di Li | M | 57 |
University of Science & Technology of China
| 10 years |
| Cheryl Mills | F | 59 |
New York University
| 7 years |
| Yu Wei Xue | M | 62 | 11 years | |
| Joe Ellis | M | - |
The University of Chicago
| 4 years |
| Pamela Kaufman | F | - |
New York University
| 4 years |
| Dora Lee | F | - |
New York University
| 6 years |
| Rodney Nelson | M | - |
The University of Chicago
| 4 years |
| Roy S. Eappen | M | - |
New York University
| 8 years |
| Qingfeng Liu | M | 50 |
University of Science & Technology of China
| 5 years |
| Bo Bai | M | - |
University of Science & Technology of China
| 6 years |
| Matthew McAviney | M | - |
The University of Chicago
| 9 years |
| Matt Hutchison | M | - |
The University of Chicago
| 3 years |
| John Beczak | M | - |
New York University
| 3 years |
| John Scotti | M | - |
The University of Chicago
| 4 years |
| Sheng Peng | M | 48 |
University of Science & Technology of China
| 6 years |
| Rui Mao | M | 49 |
University of Science & Technology of China
| 6 years |
| Xue Hong Tian | M | 49 |
University of Science & Technology of China
| 8 years |
| Ajar Ashyrkulova | M | - |
New York University
| 5 years |
| Kristine F. Treglia | F | - |
New York University
| 5 years |
| Xiang Gao | M | 42 |
University of Science & Technology of China
| 9 years |
| Justin Kern | M | - |
The University of Chicago
| 10 years |
| Young Min Ban | M | - |
New York University
| 4 years |
| Bradley Mills Feingerts | M | - |
The University of Chicago
| 4 years |
| Nuno Paixao | M | - |
The University of Chicago
| 6 years |
| Irwin Guzman | M | - |
The University of Chicago
New York University
| 7 years |
| Ke Cheng | M | - |
The University of Chicago
| 3 years |
| David Park | M | - |
New York University
| 4 years |
| Woongkee Min | M | - |
New York University
| 3 years |
| John E. Puchalla | M | - |
New York University
| 3 years |
| Neal P. Sangani | M | - |
New York University
| 4 years |
| Roman Nikolayevich Sulzhik | M | 50 |
New York University
| 2 years |
| Roman Fuzaylov | M | - |
New York University
| 4 years |
| Joe Kwan | M | - |
New York University
| 1 years |
| Jason Bhatti | M | - |
New York University
| 4 years |
| Muni Malhotra | M | - |
New York University
| 2 years |
| Ashish Bhatia | M | - |
New York University
| 4 years |
| Ivan Varela Sanchez | M | 52 |
New York University
| 2 years |
| Ezra Galston | M | - |
New York University
| 4 years |
| Andrew Ronald Hanover | M | - |
New York University
| 4 years |
| Tim Wang | M | - |
New York University
| 2 years |
| Matt Epstein | M | 41 |
New York University
| 4 years |
| Ilya A. Figelman | M | - |
New York University
| 3 years |
| Hui Wang | M | 46 |
University of Science & Technology of China
| 4 years |
| Josh Hendler | M | - |
New York University
| 4 years |
| Mitchell Seth Garfin | M | - |
New York University
| 2 years |
| Ned Daoro | M | - |
New York University
| 4 years |
| Paul Guggenheimer | M | - |
New York University
| 3 years |
| Melody Amanda Vogelmann | F | - |
New York University
| 2 years |
| John S. Neamonitis | M | - |
New York University
| 4 years |
| Irina Kogan | F | - |
New York University
| 2 years |
| Matthew Keeler | M | - |
New York University
| 4 years |
| David Lawrence Mandelbaum | M | - |
New York University
| 2 years |
| Nitin Singhal | M | - |
New York University
| - |
| Carla Chase | F | - |
New York University
| 2 years |
| Darren Yip | M | - |
New York University
| 2 years |
| Joseph P. Schlessinger | M | 79 |
New York University
| 3 years |
| Michael Albert Gayed | M | - |
New York University
| 4 years |
| Melanie Lomas | F | - |
New York University
| 2 years |
| Rajeev Lalwani | M | - |
New York University
| 4 years |
| Alex Motamed | M | - |
New York University
| 2 years |
| Marybeth Degen Henry | F | - |
New York University
| 2 years |
| Nabil Mallick | M | 40 |
New York University
| 4 years |
| Eric Richard Bertrand | M | - |
New York University
| 2 years |
| Seung-Ho Ahn | M | - |
New York University
| 4 years |
| Alex Shuaib | M | - |
New York University
| 4 years |
| Joseph Giordano | M | - |
New York University
| 4 years |
| Viraj K. Desai | M | - |
New York University
| 4 years |
| Yoram Heller | M | - |
New York University
| 4 years |
| David Judice | M | - |
New York University
| 2 years |
| Jonathan Michael Sheridan | M | - |
New York University
| 3 years |
| Catherine Xiao | F | - |
New York University
| 3 years |
| Dávid Várszegi | M | 43 |
New York University
| 3 years |
| Peter K. Chung | M | - |
New York University
| 4 years |
| Wayne Pinsent | M | 38 |
New York University
| 4 years |
| Adam Mullinax | M | - |
New York University
| 4 years |
| Laura Huang | F | - |
New York University
| 4 years |
| Mike McCartan | M | - |
New York University
| 3 years |
| Marc Gross | M | - |
New York University
| 2 years |
| Craig Guttenplan | M | - |
New York University
| 4 years |
| Pablo Caicedo | M | - |
New York University
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 74 | 74.00% |
| China | 26 | 26.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Dan Sheng
- Personal Network
